Big Pharma Losing Leverage as Payers Raise Pressure on Price
- Consolidation among insurers, pharmacy benefit managers key
- Drug companies are citing growth by volume instead of price
Trump vs. Big Pharma: Can He Bring Drug Prices Down?
This article is for subscribers only.
The world’s biggest drugmakers don’t have the muscle they used to have.
Pharmaceutical and biotechnology giants are finding it more difficult to charge high prices for a range of medications, their latest quarterly results show. That’s raising the pressure to pump up sales volumes and find lucrative new treatments for niche markets.